EAU25: Highlights from Day 3

Must-view webcasts

APPEAL – A large, international randomised controlled trial assessing the efficacy of antimicrobial prophylaxis for extracorporeal shock wave lithotripsy on reducing urinary tract infection – Prof. K.A.O. Tikkinen, Helsinki (FI) – View webcast

TRANSLATE – Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection: a multicentre, randomised, controlled trial – Assoc. Prof. R.J. Bryant, Oxford (GB), Prof. D. Murphy, Melbourne (AU) – View webcast

Challenges and nightmares in endourology
Beyond the latest devices and techniques, urologists who perform endourological procedures need to be prepared to deal with patients who are using anticoagulation therapy, especially when short-term discontinuation is not an option. These new drugs are more frequently being prescribed and can be an additional challenge for operations where blood loss is a risk. Read article.

From the congress floor in Madrid
Check out this album of all this year’s winners at the 40th Annual EAU Congress! We also have some general impressions from Day 3 for you. Share your photos and stories on Instagram as well.

PCa trials update: Finding the best way to screen men
During the Thematic Session ‘Early detection and diagnosis pathways in prostate cancer revisited’, presentations covered ongoing trials seeking the best way to screen men for prostate cancer (PCa). These trials include Göteborg, STHLM3 MRI, ProScreen, PROBASE, and TRANSFORM.

EAUTV: Prostate Cancer
In this edition of EAUTV in Madrid, we are covering prostate cancer. Moderator Dr. Jochen Walz leads the conversation with experts Dr. Laurence Klotz, Prof. Markus Graefen and Dr. Fabian Falkenbach on prostate cancer highlights.

—

What’s coming this Monday

• 08:00 – 10:00 Plenary Session: Optimising the patient journey: From prehabilitation to rehabilitation in urologic surgery
• 08:00 – 10:00 Plenary Session:  Novel technologies in urology: Affordability vs. benefits
• 10:00 – 10:30 Game Changer Session: NeuroSAFE versus standard robot-assisted radical prostatectomy and Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate and High-risk Non-metastatic Clear Cell Renal Cell Carcinoma
• 10:00 – 10:30 Game Changer Session: In this session on prostate cancer, you will be informed on the results of darolutamide + ADT in patients with mHSPC and on the long-term survival of radically radiated high-risk prostate cancer patients who received adjuvant docetaxel versus surveillance.
• 14:15 – 16:15 Special Session: Best of EAU25 – Take Home Messages. Designed for all attendees, this session provides a valuable synthesis of the congress’s rich educational content, enabling participants to integrate the latest developments into clinical practice effectively

—

Access all EAU25 scientific content
All webcasts, videos, posters and full-text abstracts are currently accessible via the EAU25 Resource Centre wherein delegates have full access. If you did not attend the congress, you can still register for on-demand access to explore all of EAU25 scientific content (accreditation is no longer valid).